Detalhe da pesquisa
1.
Transient Liver Damage and Hemolysis Are Associated With an Inhibition of Ebola Virus Glycoprotein-Specific Antibody Response and Lymphopenia.
J Infect Dis
; 225(10): 1852-1855, 2022 05 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-34791300
2.
Development and Evaluation of an Ebola Virus Glycoprotein Mucin-Like Domain Replacement System as a New Dendritic Cell-Targeting Vaccine Approach against HIV-1.
J Virol
; 95(15): e0236820, 2021 07 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-34011553
3.
The Pumilio-domain protein PUF6 contributes to SIDER2 retroposon-mediated mRNA decay in Leishmania.
RNA
; 23(12): 1874-1885, 2017 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-28877997
4.
UV-Inactivated rVSV-M2e-Based Influenza Vaccine Protected against the H1N1 Influenza Challenge.
Front Biosci (Landmark Ed)
; 29(5): 195, 2024 May 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-38812326
5.
Impact of Recombinant VSV-HIV Prime, DNA-Boost Vaccine Candidates on Immunogenicity and Viremia on SHIV-Infected Rhesus Macaques.
Vaccines (Basel)
; 12(4)2024 Mar 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-38675751
6.
Optimal Expression, Function, and Immunogenicity of an HIV-1 Vaccine Derived from the Approved Ebola Vaccine, rVSV-ZEBOV.
Vaccines (Basel)
; 11(5)2023 May 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-37243081
7.
Rhesus macaques show increased resistance to repeated SHIV intrarectal exposure following a heterologous regimen of rVSV vector vaccine expressing HIV antigen.
Emerg Microbes Infect
; 12(2): 2251595, 2023 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-37649434
8.
Development and characterization of influenza M2 ectodomain and/or hemagglutinin stalk-based dendritic cell-targeting vaccines.
Front Microbiol
; 13: 937192, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36003947
9.
A novel intradermal tattoo-based injection device enhances the immunogenicity of plasmid DNA vaccines.
NPJ Vaccines
; 7(1): 172, 2022 Dec 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-36543794
10.
Did the GJB2 35delG mutation originate in Iran?
Am J Med Genet A
; 155A(10): 2453-8, 2011 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-21910243
11.
A novel DNA platform designed for vaccine use with high transgene expression and immunogenicity.
Vaccine
; 39(49): 7175-7181, 2021 12 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-34774358
12.
In Vivo Tethering System to Isolate RNA-Binding Proteins Regulating mRNA Decay in Leishmania.
Methods Mol Biol
; 2116: 325-338, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-32221929
13.
Evaluation of novel HIV vaccine candidates using recombinant vesicular stomatitis virus vector produced in serum-free Vero cell cultures.
Vaccine
; 38(50): 7949-7955, 2020 11 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-33139138
14.
Production of rVSV-ZEBOV in serum-free suspension culture of HEK 293SF cells.
Vaccine
; 37(44): 6624-6632, 2019 10 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-31548015
15.
SIDER2 retroposon-mediated mRNA decay in Leishmania is coupled to translation.
Int J Parasitol
; 47(6): 305-310, 2017 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-28315363
16.
RNA secondary structure and nucleotide composition of the conserved hallmark sequence of Leishmania SIDER2 retroposons are essential for endonucleolytic cleavage and mRNA degradation.
PLoS One
; 12(7): e0180678, 2017.
Artigo
em Inglês
| MEDLINE | ID: mdl-28704426
17.
Development of novel prime-boost strategies based on a tri-gene fusion recombinant L. tarentolae vaccine against experimental murine visceral leishmaniasis.
PLoS Negl Trop Dis
; 7(4): e2174, 2013.
Artigo
em Inglês
| MEDLINE | ID: mdl-23638195
18.
Recombinant Leishmania tarentolae expressing the A2 virulence gene as a novel candidate vaccine against visceral leishmaniasis.
Vaccine
; 28(1): 53-62, 2009 Dec 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-19818721
19.
Cysteine proteinase type III is protective against Leishmania infantum infection in BALB/c mice and highly antigenic in visceral leishmaniasis individuals.
Vaccine
; 26(46): 5822-9, 2008 Oct 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-18804512